Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).

被引：16
|
作者：
Yarchoan, Mark [1 ]
Zhu, Qingfeng [2 ]
Durham, Jennifer N. [3 ]
Gross, Nicole [1 ]
Charmsaz, Soren [1 ]
Leatherman, James M. [4 ]
Zhang, Shu [1 ]
Popovic, Aleksandra [5 ]
Weiss, Matthew John [6 ]
Philosophe, Benjamin [7 ]
Burkhart, Richard A. [8 ]
Burns, William [9 ]
Wilt, Brad [7 ]
Sugar, Elizabeth [7 ]
Fertig, Elana J. [10 ]
Laheru, Dan [11 ]
Anders, Robert A. [2 ]
Jaffee, Elizabeth M. [10 ]
Ho, Won Jin [1 ]
机构：
[1] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins, Bloomberg Kimmel Inst Canc Immunotherapy, Dept Pathol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[6] Northwell Hlth Canc Inst, Manhasset, NY USA
[7] Johns Hopkins, Baltimore, MD USA
[8] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[9] Univ Michigan, Ann Arbor, MI 48109 USA
[10] Johns Hopkins Univ, Baltimore, MD USA
[11] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
335
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
    Qiancheng Hu
    Dan Wang
    Ye Chen
    Xiaofen Li
    Peng Cao
    Dan Cao
    [J]. Radiation Oncology, 14
  • [42] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable locally advanced esophageal squamous cell carcinoma
    Yoshinami, Y.
    Yamamoto, S.
    Shiraishi, K.
    Itoyama, M.
    Imazeki, H.
    Yokoyama, K.
    Honma, Y.
    Kurita, D.
    Ishiyama, K.
    Oguma, J.
    Daiko, H.
    Kato, K.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S168 - S168
  • [43] Combining cabozantinib, nivolumab and ipilimumab in advanced hepatocellular carcinoma: does benefit outweigh toxicity?
    Miranda, Thiago A.
    Girardi, Daniel M.
    Pereira, Allan A. L.
    [J]. CHINESE CLINICAL ONCOLOGY, 2024, 13 (03)
  • [44] Feasibility of Using Hydrogel Spacers for Borderline-Resectable and Locally Advanced Pancreatic Tumors
    Kerdsirichairat, Tossapol
    Narang, Amol K.
    Thompson, Elizabeth
    Kim, Seong-Hun
    Rao, Avani
    Ding, Kai
    Shin, Eun Ji
    [J]. GASTROENTEROLOGY, 2019, 157 (04) : 933 - 935
  • [45] Metronomic oral cyclophosphamide & low dose nivolumab for advanced hepatocellular carcinoma (HCC).
    Chen, Jo-Pai
    Kao, Tsui-Mai
    Hsueh, Fu-Jen
    Lu, Wei-Chen
    Ma, Wei-li
    Wu, Hsu
    Chiang, Keng-Man
    Chen, Hsing-wu
    Kuo, Sung-Hsin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer
    Sylvie, Lorenzen
    Silvia, Spoerl
    Salah-Eddin, Al-Batran
    Markus, Feith
    Florian, Lordick
    Peter, Thuss-Patience
    Bernhard, Haller
    Martin, Angele
    Alexander, Novotny
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (14) : 1918 - 1926
  • [47] Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications
    Chaudhari, Vikram A.
    Ostwal, Vikas
    Patkar, Shraddha
    Sahu, Arvind
    Toshniwal, Anup
    Ramaswamy, Anant
    Shetty, Nitin S.
    Shrikhande, Shailesh V.
    Goel, Mahesh
    [J]. HPB, 2018, 20 (09) : 841 - 847
  • [48] Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer
    Scheufele, Florian
    Hartmann, Daniel
    Friess, Helmut
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [49] A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
    Peter J Hosein
    Jessica Macintyre
    Carolina Kawamura
    Jennifer Cudris Maldonado
    Vinicius Ernani
    Arturo Loaiza-Bonilla
    Govindarajan Narayanan
    Afonso Ribeiro
    Lorraine Portelance
    Jaime R Merchan
    Joe U Levi
    Caio M Rocha-Lima
    [J]. BMC Cancer, 12
  • [50] Institutional experience in induction chemotherapy and neoadjuvant IMRT for borderline resectable and locally advanced pancreatic adenocarcinoma
    de Torres Olombrada, M. V.
    Garcia Canibano, T.
    Juez Martel, I.
    Gutierrez Abad, D.
    Pereira Perez, F.
    Ludena Martinez, B.
    [J]. ANNALS OF ONCOLOGY, 2015, 26
12345